Nasdaq Surges 100 Points; AngioDynamics Posts Upbeat Q1 Results
1. AngioDynamics reported better-than-expected quarterly earnings, showing improved financial performance. 2. The company posted losses of 10 cents per share, beating estimates by 2 cents. 3. Quarterly sales reached $75.711 million, exceeding the consensus of $72.725 million. 4. AngioDynamics raised its FY26 adjusted EPS and sales guidance, indicating positive future outlook.